Length of stay and mortality due to Clostridium difficile infection acquired in the intensive care unit

Journal of Critical Care

Volumn 28, Issue 4, 2013, Pages 335-340

  Dodek, Peter M ^a,b,c   Norena, Monica ^a,c   Ayas, Najib T ^a,b,c,d   Romney, Marc ^c   Wong, Hubert ^a,c,e  

^a Center for Health Evaluation and Outcome Sciences   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^d Center for Clinical Epidemiology and Evaluation   (Canada)

^e Centre for Health Services and Policy Research   (Canada)

Author keywords

Clostridium difficile infection; Intensive care unit; Length of stay; Mortality

Indexed keywords

ADULT; AGE; ARTICLE; CLOSTRIDIUM DIFFICILE INFECTION; COHORT ANALYSIS; CONTROLLED STUDY; DEATH; DISEASE SEVERITY; FEMALE; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HOSPITAL INFECTION; HUMAN; INFECTION RISK; INTENSIVE CARE UNIT; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MORTALITY; RETROSPECTIVE STUDY; SEX; APACHE; CANADA; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTION; CROSS INFECTION; MULTICENTER STUDY; PROPORTIONAL HAZARDS MODEL; SEVERITY OF ILLNESS INDEX; STATISTICS;

CLOSTRIDIUM DIFFICILE INFECTION; INTENSIVE CARE UNIT; LENGTH OF STAY; MORTALITY;

APACHE; BRITISH COLUMBIA; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTIONS; CROSS INFECTION; FEMALE; HUMANS; INTENSIVE CARE UNITS; LENGTH OF STAY; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX;

EID: 84886707828     PISSN: 08839441     EISSN: 15578615     Source Type: Journal    
DOI: 10.1016/j.jcrc.2012.11.008     Document Type: Article

References (33)

1. Baker G.R., Norton P.G., Flintoft V., et al. The Canadian Adverse Events Study: the incidence of adverse events among hospital patients in Canada. CMAJ 2004, 170:1678-1686.
2. Cullen D.J., Sweitzer B.J., Bates D.W., Burdick E., Edmondson A., Leape L.L. Preventable adverse drug events in hospitalized patients: a comparative study of intensive care and general care units. Crit Care Med 1997, 25:1289-1297.
3. Bobo L.D., Dubberke E.R., Kollef M. Clostridium difficile in the ICU: the struggle continues. Chest 2011, 140:1643-1653.
4. Loo V.G., Bourgault A., Poirier L., et al. Host and pathogen factors for Clostridium difficile infection and colonization. N Engl J Med 2011, 365:1693-1703.
5. Eriksson S., Aronsson B. Medical implications of nosocomial infection with Clostridium difficile. Scand J Infect Dis 1989, 212:733-734.
6. Macgowan A.P., Brown I., Feeney R., et al. Clostridium difficile-associated diarrhea and length of hospital stay. J Hosp Infect 1995, 31:241-244.
7. Riley T.V., Codde J.P., Rouse I.L. Increased length of hospital stay due to Clostridium difficile associated diarrhea. Lancet 1995, 345:455-456.
8. MacGowan A.P., Feeney R., Brown I., McCulloch S.Y., Reeves D.S., Lovering A.M. Health care resource utilization and antimicrobial use in elderly patients with community-acquired lower respiratory tract infection who develop Clostridium difficile-associated diarrhoea. J Antimicrob Chemother 1997, 39:537-541.
9. Kyne L., Hamel M.B., Polavaram R., Kelly C.P. Health care costs and mortality associated with nosocomial diarrhea due to Clostridium difficile. Clin Infect Dis 2002, 34:346-353.
10. Pépin J., Valiquette Cossette B. Mortality attributable to nosocomial Clostridium difficile-associated disease during an epidemic caused by a hypervirulent strain in Quebec. CMAJ 2005, 173:1037-1041.
11. Marcon A.P., Gamba M.A., Vianna L.A.C. Nosocomial diarrhea in the intensive care unit. Braz J Infect Dis 2006, 10:384-389.
12. Ang C.W., Heyes G., Morrison P., Carr B. The acquisition and outcome of ICU-acquired Clostridium difficile infection in a single centre in the UK. J Infect 2008, 57:435-440.
13. Dubberke E.R., Butler A.M., Reske K.A., et al. Attributable outcomes of endemic Clostridium difficile-associated disease in non-surgical patients. Emerg Infect Dis 2008, 14:1031-1038.
14. Gasperino J., Garala M., Cohen H.W., Kvetan V., Currie B. Investigation of critical care unit utilization and mortality in patients infected with Clostridium difficile. J Crit Care 2010, 25:282-286.
15. Bajaj J.S., Ananthakrishnan A.N., Hafeeaullah M., et al. Clostridium difficile is associated with poor outcomes in patients with cirrhosis: a national a tertiary center perspective. Am J Gastroenterol 2010, 105:106-113.
16. Oake N., Taljaard M., van Walraven C., Wilson K., Roth V., Forster A.J. The effect of hospital-acquired Clostridium difficile infection on in-hospital mortality. Arch Intern Med 2010, 170:1804-1810.
17. Glance L.G., Stone P.W., Mukamel D.B., Dick A.W. Increases in mortality, length of stay, and cost associated with hospital-acquired infections in trauma patients. Arch Surg 2011, 146:794-801.
18. Jen M.-H., Bottle S.A., Aylin P., Pollok R.C.G. Increased health burden associated with Clostridium difficile diarrhea in patients with inflammatory bowel disease. Aliment Pharmacol Ther 2011, 33:1322-1331.
19. Forster A.J., Jaljaard M., Oake N., Wilson K., Roth V., van Walraven C. The effect of hospital-acquired infection with Clostridium difficile on length of stay in hospital. CMAJ 2012, 184:37-42.
20. Zilberberg M.D., Shorr A.F., Micek S.T., Doherty J.A., Kollef M.H. Clostridium difficile-associated disease and mortality among the elderly critically ill. Crit Care Med 2009, 37:2583-2589.
21. Musa S.A., Moran C., Thomson S.J., Cowan M.L., McAnulty G., Grounds M., et al. Clostridium difficile-associated disease acquired in the cardiothoracic intensive care unit. J Cardiothorac Vasc Anesth 2011, 25:263-267.
22. Musa S.A., Robertshaw H., Thomson S.J., Cowan M.L., Rahman T.M. Clostridium difficile-associated disease acquired in the nerurocritical care unit. Neurocrit Care 2010, 13:87-92.
23. Shintani A.K., Girard T.D., Eden S.K., Arbogast P.G., Moons K.G.M., Ely E.W. Immortal time bias in critical care research: application of time-varying Cox regression for observational cohort studies. Crit Care Med 2009, 37:2939-2945.
24. Leclair M.-A., Allard C., Lesur O., Pepin J. Clostridium difficile infection in the intensive care unit. J Intensive Care Med 2010, 25:23-30.
25. Miller B.A., Chen L.F., Sexton D.J., Anderson D.J. Comparison of the burdens of hospital-onset, healthcare facility-associated Clostridium difficile infection and of healthcare-associated infection due to methicillin-resistant Staphylococcus aureus in community hospitals. Infect Control Hosp Epidemiol 2011, 32:387-390.
26. Dubberke E.R., Yan Y., Reske K.A., et al. Development and validation of a Clostridium difficile infection risk prediction model. Infect Control Hosp Epidemiol 2011, 32:360-366.
27. Janka J., O'Grady N.P. Clostridium difficile infection: current perspectives. Curr Opin Crit Care 2009, 15:149-153.
28. Ghantoji S.S., Sail K., Lairson D.R., DuPont H.L., Garey K.W. Economic healthcare costs of Clostridium difficile infection: a systematic review. J Hosp Infect 2010, 74:309-318.
29. Mitchell B.G., Gardner A. Prolongation of length of stay and Clostridium difficile infection: a review of the methods used to examine length of stay due to healthcare associated infections. Antimicrob Resist Infect Control 2012, 1:14.
30. Barnett A.G., Batra R., Graves N., Edgeworth J., Robotham J., Cooper B. Using a longitudinal model to estimate the effect of methicillin-resistant Staphylococcus aureus infection on length of stay in an intensive care unit. Am J Epidemiol 2009, 170:1186-1194.
31. Barnett A.G., Beyersmann J., Allignol A., Rosenthal V.D., Graves N., Wolkewitz M. The time-dependent bias and its effect on extra length of stay due to nosocomial infection. Value Health 2011, 14:381-386.
32. Beyersmann J., Gastmeier P., Grundmann H., et al. Use of multistate models to assess prolongation of intensive care unit stay due to nosocomial infection. Infect Control Hosp Epidemiol 2006, 27:493-499.
33. Miller M., Gravel D., Mulvey M., et al. Health care-associated Clostridium difficile infection in Canada: patient age and infecting strain type are highly predictive of severe outcome and mortality. Clin Infect Dis 2010, 50:194-201.